Transcend Capital Advisors LLC Has $833,000 Stock Position in CME Group Inc. (NASDAQ:CME)

Transcend Capital Advisors LLC raised its position in CME Group Inc. (NASDAQ:CME) by 2.6% in the 2nd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 4,238 shares of the financial services provider’s stock after acquiring an additional 106 shares during the period. Transcend Capital Advisors LLC’s holdings in CME Group were worth $833,000 as of its most recent SEC filing.

Several other large investors have also recently added to or reduced their stakes in the company. B. Riley Wealth Advisors Inc. raised its holdings in CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock valued at $782,000 after acquiring an additional 48 shares in the last quarter. Capital Advisors Ltd. LLC raised its holdings in CME Group by 4.3% in the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock valued at $250,000 after acquiring an additional 48 shares in the last quarter. Lantz Financial LLC raised its holdings in CME Group by 1.1% in the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock valued at $982,000 after acquiring an additional 49 shares in the last quarter. Greystone Financial Group LLC raised its holdings in CME Group by 1.6% in the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock valued at $691,000 after acquiring an additional 52 shares in the last quarter. Finally, Essex LLC raised its holdings in CME Group by 3.3% in the 1st quarter. Essex LLC now owns 1,649 shares of the financial services provider’s stock valued at $355,000 after acquiring an additional 52 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities analysts have recently issued reports on the company. Bank of America increased their target price on CME Group from $209.00 to $216.00 and gave the stock a “neutral” rating in a report on Thursday, April 25th. Morgan Stanley increased their target price on CME Group from $222.00 to $225.00 and gave the stock an “equal weight” rating in a report on Tuesday, April 9th. Rosenblatt Securities reissued a “sell” rating and issued a $187.00 target price (up from $185.00) on shares of CME Group in a report on Thursday, April 25th. Barclays increased their target price on CME Group from $208.00 to $209.00 and gave the stock an “equal weight” rating in a report on Thursday, July 25th. Finally, Keefe, Bruyette & Woods increased their target price on CME Group from $212.00 to $213.00 and gave the stock a “market perform” rating in a report on Thursday, July 25th. Three investment analysts have rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $212.64.

Insider Buying and Selling at CME Group

In other CME Group news, Director Terry L. Savage sold 2,500 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now directly owns 17,441 shares in the company, valued at approximately $3,673,946.65. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Terry L. Savage sold 2,500 shares of the stock in a transaction on Monday, May 13th. The stock was sold at an average price of $210.65, for a total value of $526,625.00. Following the transaction, the director now owns 17,441 shares of the company’s stock, valued at approximately $3,673,946.65. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Elizabeth A. Cook sold 1,000 shares of the stock in a transaction on Monday, May 20th. The shares were sold at an average price of $211.52, for a total value of $211,520.00. Following the completion of the transaction, the director now directly owns 18,241 shares in the company, valued at approximately $3,858,336.32. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 14,290 shares of company stock worth $2,957,300. Insiders own 0.30% of the company’s stock.

CME Group Price Performance

NASDAQ CME traded down $0.30 during trading hours on Monday, reaching $199.53. 1,075,062 shares of the company’s stock were exchanged, compared to its average volume of 1,953,876. The stock has a market cap of $71.84 billion, a PE ratio of 22.86, a price-to-earnings-growth ratio of 6.27 and a beta of 0.52. CME Group Inc. has a one year low of $190.70 and a one year high of $223.80. The firm has a fifty day moving average of $198.38 and a 200-day moving average of $207.01. The company has a current ratio of 1.02, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CME) last announced its quarterly earnings data on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, beating analysts’ consensus estimates of $2.53 by $0.03. The firm had revenue of $1.53 billion for the quarter, compared to analyst estimates of $1.53 billion. CME Group had a return on equity of 12.82% and a net margin of 56.98%. The business’s quarterly revenue was up 12.7% compared to the same quarter last year. During the same period last year, the company earned $2.30 EPS. On average, equities research analysts predict that CME Group Inc. will post 9.8 earnings per share for the current fiscal year.

CME Group Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were given a $1.15 dividend. The ex-dividend date of this dividend was Friday, June 7th. This represents a $4.60 dividend on an annualized basis and a yield of 2.31%. CME Group’s payout ratio is 52.33%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.